Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Head and Neck Carcinoma

Known as: CARCINOMA OF HEAD AND NECK, Carcinoma of the Head and Neck 
A carcinoma that arises from the head and neck region. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell… Expand
National Institutes of Health

Related topics

Related topics

12 relations
CSMD1 geneCUB and Sushi Domain-Containing Protein 1Cancer of HeadEpithelial Cells
Expand

Narrower (2)

Neck CarcinomaSquamous cell carcinoma of the head and neck

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
BACKGROUND Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after platinum chemotherapy have a… Expand
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
PURPOSE A subset of head and neck cancers is associated with the human papillomavirus (HPV). Viral infection is closely… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
BACKGROUND A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
BACKGROUND We conducted a multinational, randomized study to compare radiotherapy alone with radiotherapy plus cetuximab, a… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
BACKGROUND Despite the use of resection and postoperative radiotherapy, high-risk squamous-cell carcinoma of the head and neck… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
A correlative study was performed to address the impact of epidermal growth factor receptor (EGFR) overexpression on survival and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma.
BACKGROUND Epidemiologic evidence points to a connection between viral infection by the human papillomavirus (HPV) and a subgroup… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.
PURPOSE Tumor hypoxia adversely affects short term clinical radiation response of head and neck cancer lymph node metastases and… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
BACKGROUND Surgical oncologists rely heavily on the histopathological assessment of surgical margins to ensure total excision of… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
BACKGROUND Patients with head-and-neck cancers who are free of disease after local therapy remain at high risk for both recurrent… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE